
Pri-Tetra Effervescent Pessaries
Registered veterinary formulation (DRAP Reg: 075640)
Active: Each pessary contains:; Oxytetracycline (as hydrochloride): 1 gm
Pri-Tetra Effervescent Pessaries is a verified pessaries developed and manufactured by Prix Pharmaceutica (Pvt) Ltd. under strict cGMP protocols. Formulated for Cattle, Buffalo, Cows to provide consistent therapeutic efficacy and safety.
Withdrawal period: Meat: 10 days. Milk: 7 days. (Formal QA sign-off required).
Marketed by Prix Pharmaceutica (Pvt) Ltd.
Overview
Pri-Tetra Effervescent Pessaries is a verified pessaries developed and manufactured by Prix Pharmaceutica (Pvt) Ltd. under strict cGMP protocols. Formulated for Cattle, Buffalo, Cows to provide consistent therapeutic efficacy and safety.
Administration Route
Intrauterine insertion
Dosage Form
solution
Explore related Livestock solutions, our full product catalogue, and science and quality standards.
Composition
Each pessary contains:
| Active Ingredient | Strength / Quantity |
|---|---|
| Oxytetracycline (as hydrochloride) | 1 gm |
Indications
Indicated for the therapy and prevention of bacterial infections of the genital tract caused by microorganisms sensitive to oxytetracycline, particularly in retained placenta, acute/chronic endometritis, and puerperal metritis.
Dosage & Administration
Cow, Buffalo: 2 - 4 pessaries in a single administration by intrauterine route. Repeat after 24 hours if necessary.
Warnings & Precautions
For intrauterine veterinary administration only. Observe strict aseptic technique during insertion.
Withdrawal Period
Meat: 10 days. Milk: 7 days. (Formal QA sign-off required).
Storage Instructions
Store below 25°C in a dry place. Protect from heat and moisture.
Packing
36 Effervescent Pessaries per pack
Target species
Cattle, Buffalo, Cows
Product Documents
Contact Prix Pharmaceutica (Pvt) Ltd. for approved product literature and documentation.
⚠️ Safety Notice
For veterinary use only. Use according to approved product literature and under the guidance of a qualified veterinary professional.
Need guidance?
Our technical team can assist with product selection, dosage and programme development.
Technical Support📞 +92 42 36283464Product Specifications
- Product ID
- PRX-NEW-027
- Life Stages
- Adult, Young stock
- Manufacturing
- Marketed by Prix Pharmaceutica (Pvt) Ltd.
Responsible veterinary use
Product information is provided for professional veterinary reference. Follow the approved product label and consult a qualified veterinarian where appropriate.
Frequently asked questions about Pri-Tetra Effervescent Pessaries
Answers below reflect catalogue information only. Always follow the approved product label and qualified veterinary guidance.
What is Pri-Tetra Effervescent Pessaries?
Which dosage form is available for Pri-Tetra Effervescent Pessaries?
Which pack sizes are listed for Pri-Tetra Effervescent Pessaries?
Which animal category is Pri-Tetra Effervescent Pessaries listed under?
Where can product information for Pri-Tetra Effervescent Pessaries be requested?
How should the approved product label be followed?
Who should be consulted before veterinary use?
Related Products
Antibiotics
Amantacol
Registered poultry formulation
Amantacol is listed in the Prix Poultry Product Catalogue 2025 as an oral liquid in the antibiotics range. Always follow the approved product label and qualified veterinary guidance.
Antibiotics
Colis -Q
Registered poultry formulation
Colis -Q is listed in the Prix Poultry Product Catalogue 2025 as an oral liquid in the antibiotics range. Always follow the approved product label and qualified veterinary guidance.
Antibiotics
Pri-En 20 O/L
Registered poultry formulation
Pri-En 20 O/L is a veterinary oral liquid containing Enrofloxacin 20 gm per 100 ml. Distinct from Pri-En 20 injection. Always follow the approved product label and qualified veterinary guidance.
Antibiotics
Pri-Encolis
Registered poultry formulation
Pri-Encolis is listed in the Prix Poultry Product Catalogue 2025 as an oral liquid in the antibiotics range. Always follow the approved product label and qualified veterinary guidance.
Related insights
- Pakistan Veterinary Pharmaceutical Industry Outlook 2027: Regulatory Modernization, Market Dynamics, and Quality Standards
- Antimicrobial Stewardship in Livestock: Responsible Antibiotic Use, AMR Risks, and Herd Health in Pakistan
- Poultry Respiratory Disease Prevention and Farm Biosecurity in Pakistan: Clinical Insights for Commercial Broilers and Layers




